CVR 27174965Public limited company (A/S)Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)RoskildeFounded 12 May 2003
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about ROSE PHARMA A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
1
CVR registry, 2007
Gross profit
-35.2K
DKK, annual report 2016
Result
-51.8K
DKK, annual report 2016
Equity
979.3K
DKK, annual report 2016
NORDIC BIOTECH K/SCVR 26290724, 33.3% to under 50% of capital and votes, until 23 Apr 2020
Rosetta Capital I, LP20% to under 25% of capital and votes, until 23 Apr 2020
and 3 moreLeif Helth Jensenuntil 22 Aug 2018
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2629072433.3% to under 50% of capital and votes11 Jul 2016 to 23 Apr 2020
5% to under 10% of capital and votes14 Nov 2016 to 23 Apr 2020
20% to under 25% of capital and votes11 Jul 2016 to 23 Apr 2020
10% to under 15% of capital and votes11 Jul 2016 to 23 Apr 2020
5% to under 10% of capital and votes11 Jul 2016 to 23 Apr 2020
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
12 May 2003 to 2 Nov 2026.
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Gross profit | Not reported | -130 | Not reported | Not reported | -35 |
| Operating profit | Not reported | -130 | +263 | -171 | -35 |
| Result for the year | -335 | -134 | +250 | -187 | -52 |
| Equity | 1,102 | 968 | 1,218 | 1,031 | 979 |
| Total assets | 1,556 | 1,447 | 1,439 | 1,404 | 1,402 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -335note 1 | -130 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -126note 3 | 64 | 175 | 225 | Not reportednote 4 |
| ROIC (afkast af investeret kapital) | -27.8%note 5 | -10.1%note 6 | 21.6% | -10.1%note 6 | Not reportednote 4 |
DKK thousands. Annual reports via XBRL.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2016
1 Jan 2016 to 31 Dec 2016, published 12 Jun 2017
Annual report 2015
1 Jan 2015 to 31 Dec 2015, published 27 Jun 2016
Annual report 2014
1 Jan 2014 to 31 Dec 2014, published 24 Jun 2015
Annual report 2013
1 Jan 2013 to 31 Dec 2013, published 4 Jun 2014
Annual report 2012
1 Jan 2012 to 31 Dec 2012, published 29 Jun 2013
1 registered in CVR.
P-number 1009890927Universitetsparken 7, 4000 Roskilde
